Regulation of nuclear-cytoplasmic trafficking of oncoproteins is critical for growth homeostasis. Dysregulated trafficking contributes to malignancy, whereas understanding the process can reveal unique therapeutic opportunities. Here, we focus on eukaryotic translation initiation factor 4E (eIF4E), a prooncogenic protein highly elevated in many cancers, including acute myeloid leukemia (AML). Typically, eIF4E is localized to both the nucleus and cytoplasm, where it acts in export and translation of specific methyl 7-guanosine (m 7 G)-capped mRNAs, respectively. Nuclear accumulation of eIF4E in patients who have AML is correlated with increased eIF4E-dependent export of transcripts encoding oncoproteins. The subcellular localization of eIF4E closely correlates with patients' responses. During clinical responses to the m 7 G-cap competitor ribavirin, eIF4E is mainly cytoplasmic. At relapse, eIF4E reaccumulates in the nucleus, leading to elevated eIF4E-dependent mRNA export. We have identified importin 8 as a factor that directly imports eIF4E into the nucleus. We found that importin 8 is highly elevated in untreated patients with AML, leading to eIF4E nuclear accumulation. Importin 8 only imports capfree eIF4E. Cap-dependent changes to the structure of eIF4E underpin this selectivity. Indeed, m 7 G cap analogs or ribavirin prevents nuclear entry of eIF4E, which mirrors the trafficking phenotypes observed in patients with AML. Our studies also suggest that nuclear entry is important for the prooncogenic activity of eIF4E, at least in this context. These findings position nuclear trafficking of eIF4E as a critical step in its regulation and position the importin 8-eIF4E complex as a novel therapeutic target. 
eIF4E | importin 8 | nuclear import | m 7 G cap C ontrol of nuclear trafficking is critical for regulation of proliferation and survival. Here, we reveal a mechanism for the trafficking of the eukaryotic translation initiation factor 4E (eIF4E), which is elevated in an estimated 30% of cancers (1) . In mice, eIF4E overexpression alone is sufficient to drive development of a variety of cancers (2) . eIF4E acts in the nuclear export and translation of specific mRNAs (3, 4) . In fact, eIF4E enhances the export of over 3,500 mRNAs, many of which encode oncoproteins (3, (5) (6) (7) . In this way, eIF4E modulates gene expression through increasing cytoplasmic levels of transcripts via enhanced export and, in some cases, increasing the number of ribosomes associated with these transcripts in the cytoplasm. Although different elements in the target transcripts are required for the mRNA export or translation function of eIF4E, both require the methyl 7-guanosine (m 7 G) cap on the 5′ end of the mRNA. Several lines of evidence indicate that the mRNA export activity of eIF4E contributes to its oncogenic potential (5) (6) (7) (8) . Thus, understanding the mechanisms that underlie its nuclear-cytoplasmic trafficking is important.
eIF4E is not only elevated but also accumulates in the nucleus of some cancers, including subsets of acute myeloid leukemia (AML) and some lymphomas (8) (9) (10) . AML is a highly aggressive malignancy with poor overall survival (11) (12) (13) . For these cancer subtypes, the vast majority of eIF4E is found in the nucleus, correlating with highly elevated eIF4E-dependent mRNA export (9, 10, 14) . Accordingly, eIF4E activity was targeted in two AML clinical trials using ribavirin, which acts as a cap competitor (9, 14) . In these trials, ribavirin treatment impaired eIF4E activity in patients who had AML, which correlated with clinical responses, including some remissions. In vitro, eIF4E binds ribavirin under physiological solution conditions (15) (16) (17) (18) . In cell culture, ribavirin inhibits eIF4E activity, as observed by several groups (19) (20) (21) . Indeed, cell growth is no longer inhibited by ribavirin in cells pretreated with RNAi to eIF4E (21) . eIF4E localization is altered by treatment with m 7 G cap analogs or ribavirin. Specifically, m 7 G cap and ribavirin lead to cytoplasmic enrichment and nuclear depletion of eIF4E in treated cell lines and patients (15, 22, 23) . In patients, eIF4E relocalization to the cytoplasm correlates with clinical responses (9, 14) . At relapse, eIF4E redistributes to the nucleus, correlating with a loss of the eIF4E-ribavirin interaction due to either ribavirin glucuronidation or impaired cellular uptake of ribavirin (14, 18) . These clinical observations highlight the importance of identifying the molecular mechanisms that underpin eIF4E nuclear trafficking. However, there is no molecular understanding of this process. For instance, eIF4E lacks a classical nuclear localization signal (c-NLS) or a proline-tyrosine (PY)-NLS (24) . Here, we identify importin 8 as a direct mediator of eIF4E nuclear import. Further, eIF4E nuclear entry is regulated by a competition between m 7 G cap and importin 8 binding. Our findings provide insights into the control of eIF4E activity through modulation of its subcellular localization.
Significance
Dysregulated nuclear trafficking of oncoproteins contributes to cancer. Here, we study the trafficking of eukaryotic translation initiation factor 4E (eIF4E) in acute myeloid leukemia (AML), where eIF4E is highly elevated and accumulates in the nucleus. Nuclear eIF4E promotes export of networks of transcripts encoding oncoproteins. During clinical responses to eIF4E-targeted therapy in patients who have AML, the distribution of eIF4E becomes almost entirely cytoplasmic. At relapse, eIF4E is again mainly nuclear. Our studies provide a molecular understanding for eIF4E trafficking, through association with importin 8. We provide a molecular basis for importin 8 selectivity for certain forms of eIF4E and demonstrate the relevance of its nuclear localization to its oncogenic potential, thereby positioning the importin 8-eIF4E interaction as a novel therapeutic target.
Results eIF4E Is an Importin 8 Cargo. To elucidate mechanisms for its nuclear entry, we examined the ability of GST-eIF4E to bind a panel of import karyopherins (importins), including importins 4, 5, 7, 8, and 9; importin-α; and Kapβ2. All of these bacterially produced and purified importins are active because they all bind a form of yeast Ran•GTP (guanosine triphosphate) [Glutathione S-transferase (GST)-GSP1] with mutations and deletions (GST-GSP1 1-179, Q71L) that stabilize the GTP-bound state (25) (Fig. S1A ). Of the importins tested, only importin 8 bound eIF4E (Fig. 1A and Fig. S1B ). We observed that excess human wild-type Ran•GTP released importin 8 from its eIF4E cargo (Fig. 1A) a feature common to importin-cargo interactions (26) . Thus, eIF4E is a potential cargo for importin 8.
We carried out in vitro nuclear import assays (27) to establish whether the importin 8-eIF4E interaction was functional (Fig.  1B and Fig. S1 C-E). Import of GST-eIF4E was monitored in permeabilized U2OS cells using immunofluorescence in conjunction with confocal laser microscopy. Nuclear import of eIF4E was quantified using standard procedures (Fig. S1E ). We used a GST antibody to detect exogenous eIF4E specifically. Import assays were performed using a buffer with a mixture of cofactors required for karyopherin-dependent nuclear import (Materials and Methods). In the presence of this buffer, GSTeIF4E remained in the cytoplasm, whereas addition of importin 8 led to its nuclear entry ( Fig. 1B and Fig. S1E ). GST-GSP1 addition impaired importin 8-mediated entry of eIF4E ( Fig. 1B and Fig.  S1E ). Similarly, eIF4E did not enter the nucleus in the absence of wild-type human Ran (Fig. S1 D and E) . Thus, importin 8 imports eIF4E into the nucleus in vitro in a Ran-dependent fashion. Consistent with our above GST pull-down assays, addition of purified importins that did not bind eIF4E-GST (e.g., importins 4, 5, 9) did not import eIF4E into the nucleus (Fig. 1B and Fig. S1 D and E). Further, we tested if another member of the eIF4E family, eIF4E3, was also a cargo. eIF4E3 was examined because it has a similar overall fold to eIF4E but a different charge distribution (28) . Importantly, eIF4E3 was neither imported by nor bound to importin 8 ( Fig. S2) . Thus, the effects of importin 8 are not generalizable to the eIF4E family, and, similarly, not all importins import eIF4E.
Next, we assessed the role of importin 8 in eIF4E import in U2OS cells. Note that in intact cells, eIF4E forms nuclear bodies as well as being present in the nucleoplasm and cytoplasm (5, 7, 23) . Levels of nuclear eIF4E are unchanged in importin 9 knockdown cells relative to controls (Fig. 1C and Fig. S1C ). However, importin 8 knockdown reduced nuclear levels by threefold without altering eIF4E protein levels ( Fig. 1C and Fig.  S1C ). The knockdowns of importin 8 and importin 9 were validated by Western blot (Fig. S1C) . In summary, importin 8 mediates eIF4E nuclear entry in vitro and in intact cells.
Importin 8 Affects eIF4E-Dependent mRNA Export. We examined whether modulating nuclear entry of eIF4E has an impact on its mRNA export activity. To assess this effect, cells were fractionated into nuclear and cytoplasmic components and mRNA levels in each fraction were examined using quantitative PCR (qPCR) ( Fig. 2A ). Fractionation quality was assessed using U6snRNA and tRNA lys for nuclear and cytoplasmic fractions, respectively (Fig. S3C, Top) . Importantly, importin 8 knockdown, and thus cytoplasmic retention of eIF4E, led to nuclear accumulation of endogenous eIF4E mRNA export targets, such as c-Myc and Mcl-1, without altering their total mRNA levels ( Fig. 2A and Fig.  S3D , Top). Concomitantly, c-Myc and Mcl-1 protein levels were reduced, consistent with their lowered mRNA export (Fig. 2C ). Importin 8 knockdown did not affect eIF4E protein levels or mRNA export of negative controls, such as survivin and β-actin. As a specificity control, we examined the effects of importin 9 knockdown ( Fig. S3 E-H) . In contrast to importin 8, importin 9 knockdown did not impair eIF4E-dependent mRNA export or reduce protein levels of eIF4E targets. Interestingly, importin 9 knockdown led to cell death, where we postulate increased Mcl-1 levels were a compensatory mechanism unrelated to mRNA export. Thus, reduction in importin 8 specifically impairs eIF4E-dependent mRNA export through inhibition of eIF4E nuclear entry.
Conversely, importin 8 overexpression stimulated eIF4E-dependent mRNA export of Mcl-1 and c-Myc mRNAs, but not negative controls (e.g., survivin, ubiquitin) ( Fig. 2 B and Fig.  S3D , Bottom). This increased export corresponded to elevated Fig. S1 D and E. (C) Confocal micrographs monitoring endogenous eIF4E localization as a function of importin 8 knockdown (si Imp8) and importin 9 knockdown (si Imp9) versus control (si Ctrl). Western blots confirm knockdown with no effect on eIF4E levels in Figs. S1C and S3H. Each confocal micrograph is a single section through the plane of the cell with a magnification of 63× and no digital zoom. Fig. 2 . eIF4E nuclear trafficking affects its mRNA export activity. Effects of importin 8 (Imp8) knockdown on target mRNA export (A) and protein levels (C) in eIF4E-overexpressing (FLAG eIF4E) cells. Short hairpin control (shCtrl) indicates RNAi control, and c/n indicates the cytoplasmic-to-nuclear ratio. The c/n of tested mRNAs is shown. Results for endogenous eIF4E (endo eIF4E) upon importin 8 knockdown are shown in Fig. S3 A and B. Effects of importin 8 overexpression in the presence of endogenous eIF4E at the mRNA export (B) and protein levels (D) relative to vector controls (FLAG vect). Total mRNAs levels are unchanged (Fig. S3D ), and fractionation controls are shown in Fig.  S3C . Data are the mean ± SD. **P < 0.01; ***P < 0.001. ns, not significant.
c-Myc and Mcl-1 protein levels. In contrast, importin 9 overexpression did not alter the levels of eIF4E targets (Fig. S3J) . Consistently, importin 8 overexpression led to increased levels of nuclear eIF4E (Fig. S3K) . Thus, importin 8 promotes eIF4E-dependent mRNA export activity by promoting its reentry into the nucleus, a prerequisite for its export activity.
The Transformation Activity of eIF4E Is Related to Its Nuclear Localization.
Given the close ties between eIF4E-dependent mRNA export and its oncogenic potential (6, 7), we monitored the relevance of increased nuclear eIF4E trafficking to this activity (Fig. 3A) . We measured loss of contact inhibition using an anchorage-dependent foci formation assay as a function of modulating eIF4E localization using either U2OS cells or immortalized, but not transformed, fibroblasts ( Fig. 3 and Fig. S4 A-E) . First, we found that in eIF4E-overexpressing cells, importin 8 knockdown reduces foci number by about fivefold relative to RNAi controls in U2OS cells and approximately threefold effects in mouse embryonic fibroblasts (Fig.  3A and Fig. S4D ). Western blots confirm importin 8 knockdown and no change to eIF4E levels (Fig. 2C ). These observations suggest that lower levels of nuclear eIF4E reduced its prooncogenic activity. Conversely, importin 8 overexpression led to an over threefold increase of foci number relative to vector in U2OS cells and to an approximately fourfold increase in fibroblasts ( Fig. 3B and Fig. S4E ). Further, RNAi knockdown of eIF4E in importin 8-overexpressing cells completely impaired the foci formation activity of importin 8 (Fig. 3B) . Importantly, eIF4E knockdown did not alter the levels of the importin 8-FLAG construct (Fig. S4A) . Finally, importin 9 overexpression did not modulate the number of foci relative to vector (Fig. S4 B, C , and E); thus, this transformation activity is not universal for all importins. We also examined the relevance of nuclear entry to the invasion activity of eIF4E in Matrigel assays (Fig.  S4F ). Importin 8 knockdown reduced eIF4E-mediated invasion by approximately threefold relative to RNAi controls in U2OS cells. Taken together, these findings suggest that its nuclear localization increased the foci formation and invasion activities of eIF4E.
Effects of Adding an NLS to eIF4E. Given these findings, we assessed the effects of the addition of a c-NLS to eIF4E (29) . The eIF4E+ NLS protein is more nuclear than wild-type protein but still retains substantial cytoplasmic localization, suggesting it is associated with a strong nuclear export signal, as we observed previously (Fig. S5A) . This observation also suggests that eIF4E+NLS still transits between compartments but likely with a reduced cytoplasmic dwell time due to faster cycling into the nucleus. Overexpression of eIF4E+NLS led to increased eIF4E-dependent mRNA export as well as increased levels of the corresponding proteins relative to wild-type eIF4E or vector controls (Fig. S5 B   and C) (Fig. S5D) . We note that eIF4E+NLS levels were consistently lower than levels for wild-type protein, likely leading to an underestimation of its effects on mRNA export and transformation. Together, these studies suggest that increased nuclear trafficking of eIF4E via an NLS or by importin 8 overexpression increases its oncogenic potential.
Molecular Basis of the Importin 8-eIF4E Interaction. We used NMR methods to determine the molecular basis for the importin 8-eIF4E interaction. We monitored the 1 H-15 N HSQC (heteronuclear single quantum coherence) spectra of 15 N-labeled eIF4E as a function of importin 8 addition. We observed extensive signal broadening for eIF4E resonances (Fig. 4A and Fig. S6 A  and B) , which occurred because of the slower tumbling of the eIF4E-importin 8 complex (145 kDa) compared with eIF4E (25 kDa). Residues in the structured region of eIF4E were affected even at low molar ratios of importin 8 to eIF4E (e.g., at 0.03125:1), consistent with an estimated off-rate of ∼100 s −1 and a K d in the low micromolar range (assuming diffusion limited onrates). In contrast, the flexible N terminus of eIF4E is visible even at twofold excess importin 8, indicating that this region is not involved in binding (Fig. S6B) .
Our HSQC analysis indicated that regions in and around the cap-binding site were likely directly involved in the importin 8 interaction (Fig. 4C) . The m 7 G cap-binding site can be roughly divided into two regions: (i) residues W56 and W102, which bind the m 7 G moiety of the cap (1, 30) , and (ii) residues R157, K159, and K162, which form a positively charged patch to bind the phosphate moieties of the cap (1, 31) (Fig. 4D and Fig. S7A ). Analysis of intensity changes of eIF4E upon importin 8 addition revealed that the most affected residues were generally located around this positively charged patch, with minor affects distributed throughout the structure (Fig. 4C) .
Given that our NMR data pointed to the cap-binding site as a key part of the interaction surface of eIF4E, we assessed whether importin 8 also associated with cap-bound forms of eIF4E. Note that our above GST pull-down and NMR experiments used apoeIF4E. Strikingly, we observed that addition of a m G cap analog substantially reduced the affinity of eIF4E for importin 8. We confirmed this observation using a GST pull-down assay, where the eIF4E-importin 8 complex dissembled upon addition of excess m 7 GDP (Fig. 4E) . We also found that addition of m 7 G-capped mRNA, which better reflects the in vivo ligand, reduced importin 8 binding to eIF4E (Fig. 4F) . Thus, excess m 7 G-capped RNA or m 7 G cap analog prevents direct binding of eIF4E to importin 8.
These findings led us to investigate whether cap binding altered the nuclear import of eIF4E. Indeed, the presence of excess m 7 G cap analog severely impaired eIF4E nuclear entry by over 50-fold (Fig. 4H and Fig. S1F ), presumably by disrupting the eIF4E-importin 8 complex, consistent with our NMR and pulldown studies. Importantly, m 7 G cap addition did not impair entry of the eIF4E W56A cap-binding mutant (Fig. 4H and Fig. S1F ) as expected, given the 50-fold reduction in affinity of this mutant for the m 7 G cap (6) . Next, we examined the effects of m 7 G cap addition on an importin α/β cargo by monitoring trafficking of the GST-NLS-GFP cargo (31) . Import assays carried out in the presence or absence of m 7 G cap showed no difference in GST-NLS-GFP distribution, with GST-NLS-GFP located primarily in the nucleus (Fig. 4G and Fig. S1G ). From the above studies, we conclude that importin 8 only imports apo-eIF4E. Further, m 7 G cap specifically impairs import of eIF4E, but not of cargoes using other import pathways.
Inspection of the charge distribution on apo-and cap-bound eIF4E structures reveals that the large positively charged patch in apo-eIF4E centered around residues R157, K159, and K162 is Fig. 3 . Importin 8 transformation activity is eIF4E-dependent. Foci assays in U2OS cells as a function of importin 8 shRNA knockdown (A, shImp8) or importin 8 overexpression (B, FLAG Imp8). shCtrl and FLAG vect indicate corresponding controls. (Right) Foci numbers relative to controls are quantified. Data are the mean ± SD. **P < 0.01; ***P < 0.001. Western blots for FLAG Imp8 and eIF4E expression are shown in Fig. S4A . no longer present in the cap-bound form (Fig. 4 D and J) . This change occurs because m 7 G cap binding leads to closure of the W56 and W102 loops with concomitant reduction of the positive charge due to the presence of the cap analog phosphates (30) . Consistently, our NMR data indicated that residues at this positively charged surface were significantly perturbed even at low molar importin 8/eIF4E ratios (Fig. 4C) . To examine the relevance of this surface for importin 8 binding, we generated a triple mutant (TrMut) whereby R157, K159, and K162 were mutated to glutamates to imbue this surface with a negative charge (Fig.  S9 A and B) . NMR and CD studies indicated the TrMut was folded (Fig. S9 C and D) . GST pull-down experiments showed that the TrMut had a marked reduction in affinity for importin 8 relative to wild-type eIF4E (Fig. 4I) . Thus, mutation of the positive surface in the cap-binding site substantially reduces the affinity of eIF4E for importin 8. We note that mutation of W56 did not alter binding to importin 8 or nuclear trafficking of eIF4E (Fig. 4H, Right and Figs. S1F and S7 B-D) . These observations indicate that the positive patch within the cap-binding site is specifically required for importin 8 trafficking, and not the cap-binding site as a whole.
Mutation of the positive patch suggested that the interaction of eIF4E with importin 8 was electrostatically based. Thus, we examined the salt sensitivity of the interaction using NMR and pull-down assays with wild-type proteins (Fig. S9 E and F) . As expected, increasing NaCl from 100 to 500 mM impaired complex formation. Taken together with the TrMut, these studies strongly suggest that a negative patch on importin 8 interacts with the positive patch in the vacant cap-binding site. However, our HSQC data also indicate that residues throughout the eIF4E structure were perturbed by importin 8, suggesting that importin 8 contacts additional surfaces on eIF4E (Fig. 4C and Fig. S6B ). Thus, although importin 8 requires the positive patch for binding, its contacts are likely not restricted to this region. Clinical Relevance of the Importin 8-eIF4E Interaction. Given the nuclear enrichment of eIF4E in M4/M5 AML (Fig. S10) , we investigated if importin 8 levels were also dysregulated here (Fig.  5A ). We observed highly elevated importin 8 protein levels in these AML specimens compared with healthy volunteers. Actin was used as a loading control. These findings suggest that eIF4E might drive its own nuclear accumulation in these AML subtypes (see next section).
The cytoplasmic accumulation of eIF4E upon cap addition (Fig. 4H, Left) was reminiscent of observations in patients and cell lines treated with ribavirin (9, 14, 15, 23) (Fig. S10) . Further, NMR analysis indicated that both the active metabolite of ribavirin, ribavirin 5′-triphosphate (RTP), and m 7 G cap binding lead to similar conformational changes to eIF4E and that the phosphates of RTP also bind R157, K159, and K162 (17) . Consistently, we observe that RTP also inhibits nuclear import of eIF4E in vitro by over 50-fold, similar to the m 7 G cap (Fig. 5B  and Fig. S1H ). Thus, similar to the cap, RTP impairs importin 8 binding, preventing nuclear entry of eIF4E, and thereby providing a molecular basis for the cytoplasmic accumulation observed in responding patients.
Importin 8 Is an eIF4E mRNA Export Target. Given the elevated levels of importin 8 in patients with AML who have high eIF4E, we examined whether importin 8 is an eIF4E mRNA export target. First, we carried out immunoprecipitations (IPs) of endogenous eIF4E from the nuclear fraction of U2OS cells and monitored bound RNAs using qPCR. Importin 8 mRNAs were enriched in the eIF4E IPs (Fig. 5C ). Negative control mRNAs did not immunoprecipitate (e.g., Ubc). We also observed that importin 8 mRNA export and protein levels were elevated upon eIF4E overexpression (Fig. 5 D  and E) . Note that 4ESE RNA export elements are found in the 3′ UTRs of target mRNAs (5, 7) and, consistently, modulation of eIF4E did not alter the expression of the importin 8-FLAG construct generated from cDNA in our above foci assays (Fig.  S4A) . Thus, eIF4E elevates importin 8 protein levels through increased mRNA export. Future studies will determine if importin 8 mRNAs are also translation targets of eIF4E.
Discussion
We identified apo-eIF4E, but not eIF4E complexed to cap analogs, RTP, or m 7 G-capped RNAs, as an importin 8 cargo (Fig.  5F) . A positively charged patch on apo-eIF4E at the unoccupied cap-binding site is important for binding importin 8. These observations have significant functional implications. For instance, eIF4E that is associated with actively translating mRNAs is not a cargo. Importin 8 may also sequester eIF4E from target RNAs in the cytoplasm as a means of translational control; this possibility is an important area of future study. Another ramification is that eIF4E-mRNA export complexes would not be reimported into the nucleus until after the cargo release step, reducing futile mRNA export cycles in this way. This cap-dependent switch also provides a molecular explanation for the cytoplasmic accumulation of eIF4E in patients responding to ribavirin and in cell lines treated with ribavirin or cap analogs. Specifically, RTP prevents importin 8 binding to eIF4E, leading to its cytoplasmic retention as observed in patients responding to ribavirin. However, at relapse, when ribavirin is either glucuronidated or not transported into the cell (14, 18) , eIF4E is once again an importin 8 cargo and thereby accumulates in the nuclei of leukemic cells. This accumulation leads to elevated eIF4E-dependent mRNA export and is correlated with disease progression. Further, the nuclear accumulation of eIF4E in AML, coupled to its elevated mRNA export activity, suggests that cytoplasmic dwell times must be short for newly exported eIF4E-RNPs relative to the time required to form export-ready eIF4E-mRNA complexes in the nucleus. This possibility is consistent with eIF4E-dependent changes to the nuclear pore complex, which specifically enhance cytoplasmic release of eIF4E-RNA cargoes (6) . Finally, our studies suggest a link between the nuclear trafficking of eIF4E and its oncogenic potential.
Aside from eIF4E, Argonaute, SMADs (SMA-and MADrelated proteins), and SRP19 (signal recognition peptide 19) have been reported as importin 8 cargoes (32) (33) (34) . Unfortunately, no common features emerged after sequence analysis of these cargoes; however, our results suggest there is a strong electrostatic component. This possibility is consistent with our previous observation that the NLS for Kap108 (yeast importin 8) cargoes maps to disordered basic regions (35) (36) (37) (38) , although our findings here suggest that these surfaces can also be within folded domains. The principles for molecular recognition will likely become more evident once importin 8 cargo structures are determined.
Although importin 8 is the only direct mediator of eIF4E nuclear entry identified to date, it is entirely possible that other karyopherins may be found in the future to traffic eIF4E. Potential binding partners may indirectly modulate eIF4E nuclear localization, such as the hematopoietically expressed proline-rich homeodomain protein (PRH/Hex), which, when overexpressed, leads to cytoplasmic accumulation of eIF4E (39) . Indeed, Hex overexpression impairs the transformation potential of eIF4E, which is linked to inhibition of its nuclear entry (39) . Hex, which directly binds eIF4E, may compete with importin 8 for eIF4E, providing a molecular basis for the observed cytoplasmic phenotype. It is likely that other direct binding partners also play roles in eIF4E trafficking, particularly any that modulate cap binding or associate with the positive patch recognized by importin 8. In this way, concentrations and affinities of eIF4E partners will have an impact on importin 8 binding and subsequent eIF4E nuclear trafficking. Thus, it is important to note when considering our findings that importin 8 transcripts themselves are nuclear export targets of eIF4E. However, eIF4E does not abnormally accumulate in the nuclei of all high-eIF4E cancer cells. In this way, nuclear import of eIF4E is likely regulated in a multifactorial and context-dependent manner.
In conclusion, these studies provide a molecular basis for nuclear import of eIF4E and an understanding of how ligand binding modulates this process in cells and patients.
Materials and Methods
The eIF4E (pET-15b or pGEX-6p1) and importin 8 (pGEX-4T3) were purified from BL21(DE3) cells. Karyopherin binding assays were conducted in 20 mM Hepes (pH 7.4), 110 mM potassium acetate, 2 mM magnesium acetate, 0.005% Nonidet P-40, 1 mM EGTA, and 20 mM DTT. NMR spectra were acquired at 600 MHz on a Varian INOVA or Bruker Avance III HD spectrometer at 20°C. Data were processed and analyzed with NMRPipe (40) and Sparky (41) software. PyMOL (42) and Chimera (43) were used for structure rendering. The calculation and analyses of the electrostatic potentials were performed using PDB2PQR (44) and APBS (45) . Standard methods for cell culture and transfections were used, as described by Culjkovic et al. (5) . The fractionation protocol was followed as described (3, 6) . For anchorage-dependent foci assays, 500 cells were seeded per 10-cm plate for 14 d (6) and then stained with Giemsa (Sigma). For nuclear import assays, we used in vitro nuclear import assays as described by Cassany and Gerace (27) . Further information is provided in SI Materials and Methods.
For all patients in this study, written informed consent was obtained in accordance with the Declaration of Helsinki. This study received institutional review board (all sites) and Health Canada approval.
